Clinical research backs EarlySense's contact-free, at-home sleep monitor

Press enter to search
Close search
Open Menu

Clinical research backs EarlySense's contact-free, at-home sleep monitor

By Michael Johnsen - 07/18/2017

RAMAT GAN, Israel — EarlySense last week presented new research indicating that its EarlySense Live home-based sensor accurately detects sleep apnea and sleep disordered breathing in children, when compared to polysomnography, the testing process used in clinics to detect sleeping disorders. The contact-free system showed nearly 90% accuracy compared to the gold standard and calculated the Apnea/hypopnea index with a 0.9 correlation to sleep lab results.



The clinical results were presented at SLEEP 2017, the annual meeting of the Associated Professional Sleep Societies.



"The results of this study suggest that the tested sensor may be used in the future for at-home screening of children for sleep-disordered breathing for several consecutive nights, in their natural home setting," stated Asher Tal, head (emeritus) and founder of the Pediatric Pulmonary Unit and Sleep Center at Soroka Medical Center. "Accurately tracking sleep breathing patterns in children from the comfort of home, without any wires, holds great promise for the future of sleep medicine and eliminates long wait times typically associated with sleep lab appointments," he said. "It also allows parents to confer with pediatricians and determine if further sleep lab diagnosis is required."



Launched in early 2017, EarlySense Live provides users, their families and caregivers with accurate information regarding heart rate, breathing cycles, stress and sleep indicators. The at-home solution leverages EarlySense's core medical monitoring technology which has been successfully implemented globally in hospitals, rehab and skilled nursing facilities.



"Sleep apnea is a significant health risk that affects millions of people worldwide, and can result in reduced productivity and poor school performance," commented Zvika Shinar, chief scientist of EarlySense. "It is also associated with hypertension and cardiovascular disease if left untreated. Despite this, it remains a severely under-diagnosed condition."